Search - tctmd.com

Displaying 1 - 20 of 47

Sort: Relevancy | Date

November 2023: TCT, AHA, and PCR London Valves

Podcast Heart Sounds

November 2023: TCT, AHA, and PCR London Valves

November 29, 2023

FDA Approves Paradise Renal Denervation System: What Comes Next?

News Daily News

FDA Approves Paradise Renal Denervation System: What Comes Next?

November 08, 2023

Sirolimus- and Paclitaxel-Coated Balloons Well-Matched for In-Stent Restenosis

News Conference News TCT 2023

Sirolimus- and Paclitaxel-Coated Balloons Well-Matched for In-Stent Restenosis

November 02, 2023

Ultrathin Stent Holds Its Own in High-Bleeding-Risk Patients: COMPARE 60/80

News Conference News TCT 2023

Ultrathin Stent Holds Its Own in High-Bleeding-Risk Patients: COMPARE 60/80

Michael O'Riordan

November 01, 2023

PARTHENOPE Adds to Polymer-Free Stent Data, But Raises ST Questions

News Conference News TCT 2023

PARTHENOPE Adds to Polymer-Free Stent Data, But Raises ST Questions

October 31, 2023

RADIANCE Modest Renal Denervation Effect Remains at 6 Months

News Conference News TCT 2023

RADIANCE: 'Modest' Renal Denervation Effect Remains at 6 Months

October 31, 2023

BIOSTEMI: Degradable-Polymer, Ultrathin-Strut DES Shows No Late Catch-up at 5 Years

News Conference News TCT 2023

BIOSTEMI: Degradable-Polymer, Ultrathin-Strut DES Shows No Late Catch-up at 5 Years

October 27, 2023

Individual Patient-data Pooled Analysis of Endovascular Ultrasound Renal Denervation or a Sham Procedure at 6 Months in the RADIANCE Clinical Trial Program

Presentation TCT 2023

Individual Patient-data Pooled Analysis of Endovascular Ultrasound Renal Denervation or a Sham Procedure at 6 Months in the RADIANCE Clinical Trial Program

Presenter: Ajay Kirtane

October 26, 2023

No Mortality Signal for iFR in Real-world Use: SWEDEHEART

News Conference News TCT 2023

No Mortality Signal for iFR in Real-world Use: SWEDEHEART

October 26, 2023

Secondary Prevention Needs to Be Addressed in the Cath Lab!

Presentation TCT 2023

Secondary Prevention Needs to Be Addressed in the Cath Lab!

Presenter: Ajay Kirtane

October 26, 2023

AGENT-IDE Deeper Dive: Key Subgroups and Perspectives

Presentation TCT 2023

AGENT-IDE Deeper Dive: Key Subgroups and Perspectives

Presenter: Ajay Kirtane

October 25, 2023

RADIANCE Clinical Trial Program (Ultrasound Renal Denervation)

Presentation TCT 2023

RADIANCE Clinical Trial Program (Ultrasound Renal Denervation)

Presenter: Ajay Kirtane

October 25, 2023

In ACS, Ticagrelor Only After < 1 Month DAPT Beats Continuing Aspirin: T-PASS

News Conference News TCT 2023

In ACS, Ticagrelor Only After < 1 Month DAPT Beats Continuing Aspirin: T-PASS

Yael L. Maxwell

October 25, 2023

‘Light at the End of the Tunnel’ for In-Stent Restenosis: AGENT IDE Wins Big

News Conference News TCT 2023

‘Light at the End of the Tunnel’ for In-Stent Restenosis: AGENT IDE Wins Big

October 25, 2023

Upcoming Clinical Trials with the MagicTouch DCB

Presentation TCT 2023

Upcoming Clinical Trials with the MagicTouch DCB

Presenter: Ajay Kirtane

October 25, 2023

A High Standard of Clinical Evidence: Recent Key Milestones

Presentation TCT 2023

A High Standard of Clinical Evidence: Recent Key Milestones

Presenter: NULL

October 25, 2023

Are Outcome Trials Necessary for Renal Denervation Therapies?

Presentation TCT 2023

Are Outcome Trials Necessary for Renal Denervation Therapies?

Presenter: Ajay Kirtane

October 24, 2023

Establishing FFRangio as the Standard of Care

Presentation TCT 2023

Establishing FFRangio as the Standard of Care

Presenter: Ajay Kirtane

October 24, 2023

What’s Going to Be Hot at TCT 2023

News Opinion Editor's Corner

What’s Going to Be Hot at TCT 2023

October 19, 2023

Rox Heart Radio: TCT 2023

Podcast Rox Heart Radio

Rox Heart Radio: TCT 2023

September 20, 2023

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.